EUVIMEDEUVIMED entdecken
Open Access

Designing and Validating a Comprehensive Patient-Reported Outcomes Measure for Ambulatory Cancer Settings: The Revised Edmonton Symptom Assessment System for Cancer

Linda Watson iD, Claire Link iD, Siwei Qi iD, Andrea DeIure, Lindsi Chmielewski, April Hildebrand, Lisa Barbera iD

JCO Oncology Practice · 2024-12 · 20 (12) · 1764-1775

DOI: 10.1200/op.24.00088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Practice, 2024-12. Verfasst von Linda Watson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Applied Research & Patient Experience, Supportive Care Services and Patient Experience, Cancer Care Alberta, Alberta Health Services, Calgary, AB, Ca…. Hauptthemen laut MEDLINE: Patient Reported Outcome Measures, Neoplasms, Symptom Assessment. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Patient-reported outcomes (PROs) information has been routinely collected in Cancer Care Alberta (CCA) for years using the revised Edmonton Symptom Assessment System (ESAS-r) and Canadian Problem Checklist (CPC). There was interest in combining these into a more comprehensive single measure tailored to ambulatory cancer settings. The purpose of this study was to validate an expanded and redesigned ESAS-r called the ESAS-r Cancer. METHODS Stakeholder engagement, a review of the literature, and 2 years of CPC data collected in the cancer program informed the addition of six symptoms to the ESAS-r. To assess and validate the measure, 1,600 randomly sampled patients were mailed paper copies of the ESAS-r Cancer, ESAS-r, and a validated, comprehensive PRO measure called the Memorial System Assessment Scale-Short Form (MSAS-SF), which is often used with patients with cancer. Canonical Correlation Analysis and exploratory factor analyses were performed to assess concurrent and construct validity of the ESAS-r Cancer against ESAS-r, using MSAS-SF as the reference measure for comparison. Cronbach α was calculated to assess reliability. RESULTS Four hundred and sixty-one patients (29% response rate) completed all three questionnaires. ESAS-r Cancer showed higher numerical correlation than ESAS-r and accounted for more information included on MSAS-SF, explaining slightly more variance than ESAS-r (75.2% v 73.5%). The three-dimensional factor structure of ESAS-r Cancer outperformed the two-dimensional factor structure of ESAS-r. The reliability of ESAS-r Cancer was verified and found to be slightly higher than ESAS-r (Cronbach α = .903 v .884). CONCLUSION ESAS-r Cancer is now in use with patients throughout CCA. This valid and reliable PRO measure can be used by other cancer or specialized health care programs who wish to routinely assess common symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patient Reported Outcome MeasuresNeoplasmsSymptom AssessmentHumansMaleFemaleMiddle AgedAgedAdultReproducibility of ResultsSurveys and QuestionnairesAmbulatory CareAged, 80 and over

Autor:innen und Institutionen

  • Applied Research & Patient Experience, Supportive Care Services and Patient Experience, Cancer Care Alberta, Alberta Health Services, Calgary, AB, Canada.
  • Faculty of Nursing, University of Calgary, Calgary, AB, Canada.
  • Tom Baker Cancer Centre, Cancer Care Alberta, Alberta Health Services, Calgary, AB, Canada.
  • Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

ORCID-Profile: Linda Watson, Claire Link, Siwei Qi, Lisa Barbera

Zitieren

APA

Watson, L., Link, C., Qi, S., DeIure, A., Chmielewski, L., Hildebrand, A., & Barbera, L. (2024). Designing and Validating a Comprehensive Patient-Reported Outcomes Measure for Ambulatory Cancer Settings: The Revised Edmonton Symptom Assessment System for Cancer. JCO Oncology Practice, 20(12), 1764-1775. https://doi.org/10.1200/op.24.00088

Vancouver

Watson L, Link C, Qi S, DeIure A, Chmielewski L, Hildebrand A, et al. Designing and Validating a Comprehensive Patient-Reported Outcomes Measure for Ambulatory Cancer Settings: The Revised Edmonton Symptom Assessment System for Cancer. JCO Oncology Practice. 2024;20(12):1764-1775. doi:10.1200/op.24.00088

BibTeX
@article{Watson2024,
  author = {Watson, Linda and Link, Claire and Qi, Siwei and DeIure, Andrea and Chmielewski, Lindsi and Hildebrand, April and Barbera, Lisa},
  title = {Designing and Validating a Comprehensive Patient-Reported Outcomes Measure for Ambulatory Cancer Settings: The Revised Edmonton Symptom Assessment System for Cancer},
  journal = {JCO Oncology Practice},
  year = {2024},
  volume = {20},
  number = {12},
  pages = {1764--1775},
  doi = {10.1200/op.24.00088}
}
Kostenlos starten →